UK Govt Issues Brexit Wish List For Pharma Regulation; Wants Lots To Stay The Same

A position paper from the UK government has laid out some ideas for ensuring a smooth transition to a post-Brexit world in the area of regulation, with a focus on issues such as marketing authorization validity, continued regulatory oversight, inspections, and adverse drug reaction reporting.